The mechanism is so potent that GLP-1 drugs have become the fastest-growing weight loss treatment class in recent years
Moreover, at least 82.0% in all the treatment groups were aged 50 years
For example, research demonstrates that AI can assist clinicians in selecting the most appropriate treatment by analyzing a patients genomic data, lifestyle, and psychological profile [208]
Meanwhile, Novo is working on amycretin, a next-generation co-agonist of the GLP-1 and amylin receptors
How to manage diarrhea on semaglutide Diarrhea affects between 8.5% to 30% of people taking semaglutide
Goals of BED Treatment When considering the use of medication for BED treatment, it is also important to look at what the overall goals of treatment for this eating disorder